Friedemann Schad

Biography and Expertise of Friedemann Schad

Professor Dr. Friedemann Schad stands as a pivotal figure in the advancement of integrative oncology in Europe. As both a dedicated clinician and a rigorous scientist, he has committed his career to bridging the gap between conventional cancer treatment and evidence-based complementary therapies. His dual leadership at the Gemeinschaftskrankenhaus Havelhöhe in Berlin, as Head Physician of Oncology and Head of the Havelhöhe Research Institute, provides him a unique platform to translate research findings directly into clinical practice, ensuring patients benefit from a holistic and person-centered approach to care.

His work resonates profoundly with the 3rd WCTCIM’s Thematic Axis, “Contributions of TCIM to Global Public Health (Evidence-Based).” Professor Schad’s research, particularly on anthroposophic medicine, directly addresses the need for scientifically validated, non-conventional treatments for complex diseases like cancer. Therefore, his efforts align perfectly with the principles of the Gujarat Declaration, which champions science and evidence as the foundation for integrating traditional knowledge into modern healthcare. His focus on patient-centered outcomes and quality of life also embodies the congress motto pillar of fostering “Well-being Societies.”

Furthermore, the extensive clinical trial portfolio managed by Friedemann Schad provides a model for the “Integration of TCIM into Health Systems.” By demonstrating both the clinical efficacy and cost-effectiveness of integrative approaches, he provides policymakers and healthcare providers with the robust data needed to incorporate these modalities into standard care protocols. This work is crucial for realizing the goals of the WHO Traditional Medicine Strategy 2025-2034, making his expertise an invaluable asset to the global dialogue at the congress.

Professional Career

Professor Dr. Friedemann Schad’s professional journey reflects a deep and sustained commitment to advancing integrative oncology from within Germany’s established medical landscape. His career is characterized by the seamless combination of high-level clinical leadership with pioneering research, allowing him to shape both the practical application and the scientific understanding of complementary cancer care. This dual focus has enabled him to build a leading center for integrative oncology that is recognized across Europe.

His trajectory demonstrates a clear path of increasing responsibility and influence. Since completing his medical training, he has consistently held roles that allow him to influence clinical protocols, mentor new physicians, and direct large-scale research initiatives that have a tangible impact on patient care.

• 2008 – Present: Head Physician of the Center for Oncology, Hematology and Palliative Care at Gemeinschaftskrankenhaus Havelhöhe, Berlin, where he oversees all clinical activities and patient care strategies.
• 2008 – Present: Head of the Havelhöhe Research Institute (FIHH), Berlin, directing the institute’s scientific agenda and supervising numerous clinical trials in integrative medicine.
• 2001 – Present: Lecturer in Integrative Medicine at the Institute of Social Medicine, Epidemiology and Health Economics at Charité – Universitätsmedizin Berlin, contributing to the education of the next generation of medical professionals.
• Post-2001: Became a board-certified specialist in Internal Medicine and Gastroenterology, establishing a strong foundation in conventional medicine before specializing in integrative oncology.

Academic Qualifications

The academic foundation of Professor Dr. Friedemann Schad was forged at one of Europe’s most prestigious medical institutions, providing him with the rigorous scientific training that underpins his innovative work in integrative medicine. His education reflects a commitment to excellence in conventional medicine, which he later expanded upon with specialized training and a distinguished academic career. This robust background lends significant credibility to his research in complementary therapies.

His continuous engagement with academia, both as a student and now as a professor, highlights his dedication to lifelong learning and to the scholarly advancement of his field. Consequently, his qualifications position him as a respected voice in both clinical and academic circles.

• Adjunct Professor (apl. Prof.): Appointed at the University of Witten/Herdecke, affiliated with the Chair for Medical Theory, Integrative and Anthroposophic Medicine, a significant recognition of his academic contributions.
• Board Certifications: Became a board-certified specialist in Internal Medicine and Gastroenterology, demonstrating comprehensive expertise in key areas of conventional medical practice.
• Doctor of Medicine (Dr. med.): Earned his medical degree and doctorate from Charité – Universitätsmedizin Berlin in 2001, graduating from a world-renowned center for medical education and research.

Research and Publications

Professor Dr. Friedemann Schad is a prolific researcher whose work is centered on building a strong, credible evidence base for integrative oncology. With over 90 peer-reviewed publications, his research provides critical insights into the efficacy, safety, and cost-effectiveness of complementary treatments when used alongside conventional cancer care. His primary focus is on anthroposophic medicine, including therapies like mistletoe extracts, and on patient-centered outcomes that prioritize quality of life.

A landmark achievement in his career is his role as coordinator and Principal Investigator of the EU HORIZON-funded OCEANic project. This large-scale, multi-center study is designed to evaluate the cost-effectiveness and patient-reported outcomes of oncological care integrated with anthroposophic medicine, representing a major step forward in health services research for integrative medicine. Therefore, this project is a testament to his international standing and his ability to lead complex, impactful research.

His publication record includes numerous significant clinical trials. For instance, his 2024 publication on the APO-Support trial highlighted the benefits of on-ward supportive care by a multi-professional team in an integrative oncology setting. Beyond that, a highly cited 2013 study in the European Journal of Cancer demonstrated improved survival in patients with advanced pancreatic cancer who received mistletoe extract as an add-on therapy. Through such rigorous studies, Friedemann Schad continues to shape the future of evidence-based cancer care.

Academic and Research Leadership Recognitions

While formal awards are one measure of impact, the career of Professor Dr. Friedemann Schad is most notably recognized through his significant academic appointments and his leadership of internationally funded, large-scale research projects. These roles serve as powerful endorsements of his expertise, influence, and the high regard in which he is held by the European academic and scientific communities. They reflect a deep trust in his ability to steer the field of integrative oncology forward.

These prestigious positions are not merely titles; they are active roles that empower him to shape medical education, define research priorities, and lead initiatives that can change clinical practice on a broad scale. Consequently, these recognitions underscore his status as a key thought leader in his discipline.

• Coordinator of the OCEANic Project: His selection to lead the multi-center, EU HORIZON-funded OCEANic research project is a major international recognition of his leadership in integrative oncology research. This role places him at the helm of a project with significant implications for healthcare policy across Europe.
• Adjunct Professorship: His appointment as an Adjunct Professor (apl. Prof.) by the University of Witten/Herdecke is a significant academic honor. It acknowledges his substantial contributions to medical theory, research, and the field of integrative and anthroposophic medicine.

Institutional and Research Leadership

Professor Dr. Friedemann Schad‘s influence extends through his substantial leadership roles within key medical and academic institutions. These positions involve strategic oversight, program development, and the mentorship of future healthcare professionals. His activities in these capacities are fundamental to the institutionalization and sustained growth of integrative medicine. He actively shapes the environments where innovative care models are developed and tested.

Through this work, he ensures that integrative oncology is not only practiced but also systematically studied and taught in respected establishments. His leadership is therefore instrumental in building the infrastructure necessary for the continued advancement and acceptance of the field.

• Head of Center for Oncology, Gemeinschaftskrankenhaus Havelhöhe: In this role, he is responsible for the clinical direction, quality of care, and strategic development of one of Germany’s leading integrative oncology departments.
• Head of Havelhöhe Research Institute (FIHH): As the director of the research arm of the hospital, he guides the scientific vision, oversees all clinical trials, and ensures the methodological rigor of the institute’s output.
• Lecturer at Charité – Universitätsmedizin Berlin: His long-standing teaching position at this premier medical university allows him to directly influence medical education, introducing principles of integrative medicine to students and residents.
• Professor at University of Witten/Herdecke: His affiliation with the Chair for Medical Theory, Integrative and Anthroposophic Medicine involves him in higher-level academic discourse and contributes to the scholarly development of the discipline.

Connect with Professor Schad

For further information on the work of Professor Dr. Friedemann Schad, including his extensive list of publications, clinical activities, and research projects, please consult the following professional and academic resources. These links provide comprehensive insight into his contributions to the field of integrative oncology.

Official ORCID Profile: View Publications and Professional Activities

Google Scholar Profile: Explore Academic Publications and Citations

Gemeinschaftskrankenhaus Havelhöhe Profile: View Clinical Profile

Havelhöhe Research Institute (FIHH) Profile: View Research Leadership Profile

University of Witten/Herdecke Profile: View Academic Profile